Evidence map›Paper›PMID 40520636›Full record

ReviewPeerJ2025

Advances in drug resistance and resistance mechanisms of four colorectal cancer-associated gut microbiota.

Yu Gan, Hao Yang, Maijian Wang, Jida Li

Abstract readReview
In one paragraph

Review in PeerJ, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yu GanInstitute of Zoonosis, College of Public Health, Zunyi Medical University, Zunyi, Guizhou, China.
Hao YangXingyi City Disease Prevention and Control Center (Municipal Health Supervision Station), Xingyi, Guizhou, China.
Maijian WangInstitute of Gastrointestinal, Affiliate Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Jida LiInstitute of Zoonosis, College of Public Health, Zunyi Medical University, Zunyi, Guizhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) is a common malignant tumor in the gastrointestinal tract with inconspicuous early symptoms, high morbidity and mortality, and poor prognosis. Gut microbiota are present in the human intestinal system and have certain functions, which include the integrity of the epithelial barrier and the enhancement of protective immune responses. The etiology of CRC is numerous and complex, including poor lifestyle and dietary habits, and instability of the gut microbiota, which is considered to be one of the major factors in the development of CRC, includes mainly

Indexed as

Colorectal NeoplasmsDrug Resistance, BacterialDrug Resistance, NeoplasmGastrointestinal MicrobiomeAnti-Bacterial AgentsBacteroides fragilisDysbiosisEnterococcus faecalisEscherichia coliFusobacterium nucleatumHumansAnti-Bacterial AgentsBacteroides fragilisColorectal cancerDrug resistance mechanismEnterococcus faecalisEnterotoxin-producing Escherichia coliFusobacterium nucleatum

Identifiers

PMID40520636
PMCPMC12164818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.